Literature DB >> 30425321

Structural insights into Cas13b-guided CRISPR RNA maturation and recognition.

Bo Zhang1,2, Weiwei Ye1, Yangmiao Ye1, Huan Zhou3, Abdullah F U H Saeed1, Jing Chen1, Jinying Lin1, Vanja Perčulija1, Qi Chen1, Chun-Jung Chen4, Ming-Xian Chang5, Muhammad Iqbal Choudhary6, Songying Ouyang7,8,9.   

Abstract

Mesh:

Substances:

Year:  2018        PMID: 30425321      PMCID: PMC6274644          DOI: 10.1038/s41422-018-0109-4

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


× No keyword cloud information.
  15 in total

Review 1.  CRISPR-Cas9 Structures and Mechanisms.

Authors:  Fuguo Jiang; Jennifer A Doudna
Journal:  Annu Rev Biophys       Date:  2017-03-30       Impact factor: 12.981

2.  Two Distant Catalytic Sites Are Responsible for C2c2 RNase Activities.

Authors:  Liang Liu; Xueyan Li; Jiuyu Wang; Min Wang; Peng Chen; Maolu Yin; Jiazhi Li; Gang Sheng; Yanli Wang
Journal:  Cell       Date:  2017-01-12       Impact factor: 41.582

3.  The Molecular Architecture for RNA-Guided RNA Cleavage by Cas13a.

Authors:  Liang Liu; Xueyan Li; Jun Ma; Zongqiang Li; Lilan You; Jiuyu Wang; Min Wang; Xinzheng Zhang; Yanli Wang
Journal:  Cell       Date:  2017-07-27       Impact factor: 41.582

4.  Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6.

Authors:  Jonathan S Gootenberg; Omar O Abudayyeh; Max J Kellner; Julia Joung; James J Collins; Feng Zhang
Journal:  Science       Date:  2018-02-15       Impact factor: 47.728

5.  Diversity and evolution of class 2 CRISPR-Cas systems.

Authors:  Sergey Shmakov; Aaron Smargon; David Scott; David Cox; Neena Pyzocha; Winston Yan; Omar O Abudayyeh; Jonathan S Gootenberg; Kira S Makarova; Yuri I Wolf; Konstantin Severinov; Feng Zhang; Eugene V Koonin
Journal:  Nat Rev Microbiol       Date:  2017-01-23       Impact factor: 60.633

6.  Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors.

Authors:  Silvana Konermann; Peter Lotfy; Nicholas J Brideau; Jennifer Oki; Maxim N Shokhirev; Patrick D Hsu
Journal:  Cell       Date:  2018-03-15       Impact factor: 41.582

7.  Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection.

Authors:  Alexandra East-Seletsky; Mitchell R O'Connell; Spencer C Knight; David Burstein; Jamie H D Cate; Robert Tjian; Jennifer A Doudna
Journal:  Nature       Date:  2016-09-26       Impact factor: 49.962

8.  RNA editing with CRISPR-Cas13.

Authors:  David B T Cox; Jonathan S Gootenberg; Omar O Abudayyeh; Brian Franklin; Max J Kellner; Julia Joung; Feng Zhang
Journal:  Science       Date:  2017-10-25       Impact factor: 47.728

9.  C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector.

Authors:  Omar O Abudayyeh; Jonathan S Gootenberg; Silvana Konermann; Julia Joung; Ian M Slaymaker; David B T Cox; Sergey Shmakov; Kira S Makarova; Ekaterina Semenova; Leonid Minakhin; Konstantin Severinov; Aviv Regev; Eric S Lander; Eugene V Koonin; Feng Zhang
Journal:  Science       Date:  2016-06-02       Impact factor: 47.728

10.  Cas13d Is a Compact RNA-Targeting Type VI CRISPR Effector Positively Modulated by a WYL-Domain-Containing Accessory Protein.

Authors:  Winston X Yan; Shaorong Chong; Huaibin Zhang; Kira S Makarova; Eugene V Koonin; David R Cheng; David A Scott
Journal:  Mol Cell       Date:  2018-03-15       Impact factor: 17.970

View more
  15 in total

1.  Structural basis for self-cleavage prevention by tag:anti-tag pairing complementarity in type VI Cas13 CRISPR systems.

Authors:  Beibei Wang; Tianlong Zhang; Jun Yin; You Yu; Wenhao Xu; Jianping Ding; Dinshaw J Patel; Hui Yang
Journal:  Mol Cell       Date:  2021-01-19       Impact factor: 17.970

2.  Bacterial expression, purification, and initial characterization of a full-length Cas13b protein from Porphyromonas gingivalis.

Authors:  Jiang Zhu; Xia Zhou; Xiaolan Huang; Zhihua Du
Journal:  Protein Expr Purif       Date:  2020-01-30       Impact factor: 1.650

3.  Genetically encoded chemical crosslinking of RNA in vivo.

Authors:  Wei Sun; Nanxi Wang; Hongjiang Liu; Bingchen Yu; Ling Jin; Xingjie Ren; Yin Shen; Lei Wang
Journal:  Nat Chem       Date:  2022-10-06       Impact factor: 24.274

4.  Structure and engineering of the minimal type VI CRISPR-Cas13bt3.

Authors:  Ryoya Nakagawa; Soumya Kannan; Han Altae-Tran; Satoru N Takeda; Atsuhiro Tomita; Hisato Hirano; Tsukasa Kusakizako; Tomohiro Nishizawa; Keitaro Yamashita; Feng Zhang; Hiroshi Nishimasu; Osamu Nureki
Journal:  Mol Cell       Date:  2022-08-25       Impact factor: 19.328

5.  A phage-encoded anti-CRISPR enables complete evasion of type VI-A CRISPR-Cas immunity.

Authors:  Alexander J Meeske; Ning Jia; Alice K Cassel; Albina Kozlova; Jingqiu Liao; Martin Wiedmann; Dinshaw J Patel; Luciano A Marraffini
Journal:  Science       Date:  2020-05-28       Impact factor: 47.728

6.  It takes two (Las1 HEPN endoribonuclease domains) to cut RNA correctly.

Authors:  Monica C Pillon; Kevin H Goslen; Jacob Gordon; Melissa L Wells; Jason G Williams; Robin E Stanley
Journal:  J Biol Chem       Date:  2020-03-27       Impact factor: 5.157

Review 7.  RNA-targeting CRISPR systems from metagenomic discovery to transcriptomic engineering.

Authors:  Aaron A Smargon; Yilan J Shi; Gene W Yeo
Journal:  Nat Cell Biol       Date:  2020-02-03       Impact factor: 28.824

Review 8.  HEPN RNases - an emerging class of functionally distinct RNA processing and degradation enzymes.

Authors:  Monica C Pillon; Jacob Gordon; Meredith N Frazier; Robin E Stanley
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-12-22       Impact factor: 8.250

9.  Mechanistic insights into the R-loop formation and cleavage in CRISPR-Cas12i1.

Authors:  Bo Zhang; Diyin Luo; Yu Li; Vanja Perčulija; Jing Chen; Jinying Lin; Yangmiao Ye; Songying Ouyang
Journal:  Nat Commun       Date:  2021-06-09       Impact factor: 14.919

Review 10.  Functional Features and Current Applications of the RNA-Targeting Type VI CRISPR-Cas Systems.

Authors:  Vanja Perčulija; Jinying Lin; Bo Zhang; Songying Ouyang
Journal:  Adv Sci (Weinh)       Date:  2021-05-05       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.